KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Total Debt (2016 - 2025)

Historic Total Debt for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $49.0 billion.

  • Bristol Myers Squibb's Total Debt fell 155.57% to $49.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $49.0 billion, marking a year-over-year decrease of 155.57%. This contributed to the annual value of $49.6 billion for FY2024, which is 2483.41% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Total Debt of $49.0 billion as of Q3 2025, which was down 155.57% from $49.2 billion recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Total Debt peaked at $55.7 billion during Q1 2024, and registered a low of $37.6 billion during Q3 2023.
  • Moreover, its 5-year median value for Total Debt was $45.0 billion (2022), whereas its average is $45.0 billion.
  • Its Total Debt has fluctuated over the past 5 years, first crashed by 1588.1% in 2023, then soared by 4717.68% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Total Debt (Quarter) stood at $44.6 billion in 2021, then fell by 11.75% to $39.3 billion in 2022, then grew by 1.15% to $39.8 billion in 2023, then increased by 24.83% to $49.6 billion in 2024, then decreased by 1.35% to $49.0 billion in 2025.
  • Its last three reported values are $49.0 billion in Q3 2025, $49.2 billion for Q2 2025, and $49.7 billion during Q1 2025.